Development and Evaluation of Lactose-Free Single-Unit and Multiple-Unit Preparations of a BCS Class II Drug, Rivaroxaban.
Saved in:
| Title: | Development and Evaluation of Lactose-Free Single-Unit and Multiple-Unit Preparations of a BCS Class II Drug, Rivaroxaban. |
|---|---|
| Authors: | Zakowiecki, Daniel1 (AUTHOR) daniel.zakowiecki@budenheim.com, Edinger, Peter1 (AUTHOR), Papaioannou, Markos1 (AUTHOR), Wagner, Michael1 (AUTHOR), Hess, Tobias1 (AUTHOR), Paszkowska, Jadwiga2 (AUTHOR) g.garbacz@physiolution.pl, Staniszewska, Marcela2 (AUTHOR), Myslitska, Daria2 (AUTHOR), Smolenski, Michal2 (AUTHOR), Dobosz, Justyna2 (AUTHOR), Garbacz, Grzegorz2,3 (AUTHOR), Haznar Garbacz, Dorota4 (AUTHOR) |
| Source: | Pharmaceutics. Nov2024, Vol. 16 Issue 11, p1485. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994923 |
|---|---|
| DOI: | 10.3390/pharmaceutics16111485 |